XML 82 R227.htm IDEA: XBRL DOCUMENT v3.20.1
35 Financial Instruments (Details 10) - BRL (R$)
R$ / shares in Units, R$ in Thousands
 12 Months Ended
Jan. 02, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Disclosure of detailed information about financial instruments [line items]          
Less: Cash and cash equivalents   R$ (2,941,727) R$ (1,948,409) R$ (1,040,075) R$ (982,073)
Net income R$ 2,070,551 2,062,869 1,444,004 1,118,255  
Deferred IRPJ and CSLL   205,771 (68,072) (105,257)  
Provision for IRPJ and CSLL   433,555 580,065 379,943  
Depreciation and amortization   1,093,836 749,179 R$ 731,599  
Capital Management Risk [Member]          
Disclosure of detailed information about financial instruments [line items]          
Loans and financing   3,142,383 4,047,307    
Debentures   8,429,710 7,518,131    
Less: Cash and cash equivalents   (2,941,727) (1,948,409)    
Less: Bonds and securities (current)   (3,112) (124,862)    
Less: Bonds and securities (noncurrent)   (121,617) (112,604)    
Less: Collaterals and escrow accounts STN   (98,433) (89,555)    
Adjusted net debt   8,407,204 9,290,008    
Net income   2,062,869 1,444,004    
Equity in earnings of investees   (106,757) (135,888)    
Deferred IRPJ and CSLL   205,771 (68,072)    
Provision for IRPJ and CSLL   433,555 580,065    
Financial expenses (income), net   (488,486) (438,050)    
Depreciation and amortization   1,093,836 749,179    
Adjusted ebitda   R$ 4,177,760 R$ 3,007,338    
Adjusted net debt / Ebitda (in R$ per share)   R$ 2.01 R$ 3.09